The Claim
Among acute coronary syndrome patients who have achieved guideline-recommended LDL-C levels below 55 mg/dL, 16.4% experience a major adverse cardiac or cerebrovascular event within one year, indicating that current lipid-lowering targets do not eliminate residual cardiovascular risk in this high-risk population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Even when acute coronary syndrome patients reach the lowest recommended LDL cholesterol levels, about 1 in 6 still have a serious heart or brain event within a year, showing that current cholesterol goals do not fully prevent future cardiovascular events in these high-risk individuals.
See the scientific wording
Despite achieving guideline-recommended LDL-C targets below 55 mg/dL, 16.4% of acute coronary syndrome patients experience a major adverse cardiac or cerebrovascular event within one year, indicating that current lipid-lowering goals do not eliminate residual cardiovascular risk in high-risk populations.
Even when bad cholesterol is very low, the inside of blood vessels stays inflamed and damaged, causing clots to form and block arteries, leading to heart attacks or strokes.
What the research says
1 studyEven when heart attack patients get their bad cholesterol below the recommended level, more than 1 in 6 still have another serious heart or brain problem within a year. This means lowering cholesterol alone isn’t enough to keep the sickest patients safe.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.